Original Literature | Model OverView |
---|---|
Publication
Title
The SAP family of adaptors in immune regulation.
Affiliation
Unite INSERM U429, Hopital Necker Enfants-Malades, 149 rue de Sevres, 75015Paris, France. latour@necker.fr
Abstract
SAP and EAT-2 define a new class of adaptor proteins composed almost exclusivelyof a Src homology 2 (SH2) domain. By way of their SH2 domain, SAP-like adaptorsinteract with tyrosine-based motifs in the cytoplasmic region of SLAM-relatedreceptors, a family of immune cell-specific molecules involved inimmunoregulation. Recent findings indicate that SAP is required for thefunctions of SLAM family receptors, as a consequence of its ability to promoterecruitment of Src-related protein tyrosine kinase FynT and allow SLAM-relatedreceptors to transduce tyrosine phosphorylation signals. SAP is mutated inX-linked lymphoproliferative (XLP) syndrome, a rare inherited human diseasecharacterized by an deregulated immune response to Epstein-Barr virus infection.Several lines of evidence indicate that defects in the activities ofSLAM-related receptors caused by SAP deficiency account for the immunedysfunctions associated with XLP.
PMID
15541655
|
Entity
IFNgamma
--
MO000016665
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1639
10
infinite
0
InterPro | IPR002069 |
TRANSPATH | MO000016665 |
--
SLAM
--
MO000017813
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2565
10
infinite
0
TRANSPATH | MO000017813 |
--
SAP
--
MO000017814
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2566
10
infinite
0
TRANSPATH | MO000017814 |
--
2B4
--
MO000063033
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m37916
10
infinite
0
TRANSPATH | MO000063033 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
--
e11
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m11
0
infinite
0
--
--
e12
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m12
0
infinite
0
--
--
e13
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m13
0
infinite
0
--
--
e14
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m14
0
infinite
0
--
--
e15
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m15
0
infinite
0
--
--
e16
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m16
0
infinite
0
--
--
e17
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m17
0
infinite
0
--
--
e18
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m18
0
infinite
0
--
--
e19
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
--
e20
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m20
0
infinite
0
--
--
e21
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m21
0
infinite
0
--
--
e22
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m22
0
infinite
0
--
--
e23
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m23
0
infinite
0
--
--
e24
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m24
0
infinite
0
--
--
e25
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m25
0
infinite
0
--
--
e26
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m26
0
infinite
0
--
--
e27
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m27
0
infinite
0
--
--
e28
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m28
0
infinite
0
--
--
e29
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
--
e30
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m30
0
infinite
0
--
--
e31
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m31
0
infinite
0
--
SLAM: SLAM
--
e33
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m33
0
infinite
0
--
CD84: CD84
--
e35
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m35
0
infinite
0
--
CD84: 2B4: SAP
--
e36
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m36
0
infinite
0
--
CD48: CD48: SAP
--
e37
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m37
0
infinite
0
--
NTB-A: NTB-A
--
e39
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m39
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
NTB-A: NTB-A: SAP
--
e40
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m40
0
infinite
0
--
SLAM: SLAM: SAP: FynT
--
e42
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m42
0
infinite
0
--
SLAM: SLAM {pY}: SAP: FynT
--
e43
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m43
0
infinite
0
--
SLAM: SLAM {pY}: SAP: FynT: SHIP
--
e44
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m44
0
infinite
0
--
SLAM: SLAM {pY}: SAP: FynT: SHIP {pY}
--
e45
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m45
0
infinite
0
--
SLAM: SLAM {pY}: SAP: FynT: SHIP {pY}: DOK-1: DOK-2: Shc; Ras-GTPase
--
e46
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m46
0
infinite
0
--
DOK-1
--
e47
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m47
0
infinite
0
--
csml-variable:Double
m48
0
infinite
0
--
Ras-GTPase
--
e49
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m49
0
infinite
0
--
SLAM: SLAM: SAP
--
e5
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
CD84: 2B4
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
CD-40 ligand
--
e63
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m63
0
infinite
0
--
CD40: CD40 ligand
--
e64
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m65
0
infinite
0
--
IL-1beta receptor
--
e65
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m66
0
infinite
0
--
LPS
--
e66
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m67
0
infinite
0
--
IL-1beta: IL-1beta receptor
--
e67
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m68
0
infinite
0
--
LPS: LPS receptor
--
e68
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m69
0
infinite
0
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
IFNgamma receptor
--
e70
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m71
0
infinite
0
--
IFNgamma: IFNgamma receptor
--
e71
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m72
0
infinite
0
--
Anti SLAM antibody
--
e72
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m73
0
infinite
0
--
Anti SLAM antibody: SLAM
--
e73
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m74
0
infinite
0
--
NCR
--
e74
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m75
0
infinite
0
--
csml-variable:Double
m76
0
infinite
0
--
CD84: 2B4: SAP: FynT
--
e76
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m77
0
infinite
0
--
PLCgamma
--
e77
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m78
0
infinite
0
--
Ca
--
e78
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m79
0
infinite
0
--
2B4: LAT
--
e79
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m80
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
NTB-A antibody
--
e80
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m81
0
infinite
0
--
NTB-A antibody: NTB-A
--
e81
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m82
0
infinite
0
--
NTB-A antibody: NTB-A: SAP
--
e82
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m83
0
infinite
0
--
CD84: CD84{pY}
--
e84
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m85
0
infinite
0
--
csml-variable:Double
m86
0
infinite
0
--
CD84 antibody: CD84
--
e86
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m87
0
infinite
0
--
CD48: CD48: SAP: CD3
--
e87
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m88
0
infinite
0
--
Lyn-9 antibody
--
e88
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m89
0
infinite
0
--
Lyn-9 antibody: Lyn-9
--
e89
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m91
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
Lyn-9 antibody: Lyn-9: SAP
--
e91
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m93
0
infinite
0
--
Lyn-9 antibody: Lyn-9 {pY}: SAP
--
e92
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m94
0
infinite
0
--
CARCC
--
e93
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m95
0
infinite
0
--
SAP: CRACC
--
e94
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m96
0
infinite
0
--
2B4: LAT {pY}
--
e95
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m97
0
infinite
0
--
2B4: PI3K
--
e96
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m98
0
infinite
0
--
e97
--
e97
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m100
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c2 : 1
stoichiometry:c1 : 1
stoichiometry:c3 : 1
m2566*m33*0.1
nodelay
--
0
PMID: 15541655 SAP binds to tyrosines in the intra-cytoplasmic domain of SLAM family receptors. PMID: 15541655, 9774102, 11698418, 12928397 SAP interacts by way of its SH2 domain with tyrosine-based motifs in the cytoplasmic domain of SLAM family receptors, including SLAM, 2B4, CD84, NTB-A (Ly-108 in the mouse), Ly-9.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c29 : 1
m42*0.1
nodelay
--
0
PMID: 15541655 This leads to tyrosine phosphorylation of the receptor, and recruitment and activation of downstream effectors that activate cellular responses.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c30 : 1
stoichiometry:c32 : 1
stoichiometry:c31 : 1
m43*m2000*0.1
nodelay
--
0
PMID: 15541655 Tyrosine phosphorylation of SLAM initiates signalling, by first recruiting SHIP-1 as a result of an association between phosphorylated Y315 or Y335 and the SHIP-1 SH2 domain.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c33 : 1
stoichiometry:c34 : 1
m44*0.1
nodelay
--
0
PMID: 15541655 This binding induces tyrosine phosphorylation of SHIP-1, and subsequent recruitment of the adaptors Dok-1, Dok-2 and Shc, as well as of the Ras-GTPase-activating protein (Ras-GAP).
p13
p13
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
stoichiometry:c40 : 1
stoichiometry:c36 : 1
m45*m47*m48*m49*m64*0.1
nodelay
--
0
PMID: 15541655 This binding induces tyrosine phosphorylation of SHIP-1, and subsequent recruitment of the adaptors Dok-1, Dok-2 and Shc, as well as of the Ras-GTPase-activating protein (Ras-GAP).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
stoichiometry:c43 : 1
m1837*m63*0.1
nodelay
--
0
PMID: 15541655, 11544303, 11489980 expression of SLAM is markedly increased on DCs and B cells following activation through CD40, as well as in response to inflammatory stimuli such as lipopolysaccharide (LPS) or IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m66*m1591*0.1
nodelay
--
0
PMID: 15541655, 11544303, 11489980 expression of SLAM is markedly increased on DCs and B cells following activation through CD40, as well as in response to inflammatory stimuli such as lipopolysaccharide (LPS) or IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m67*m155666*0.1
nodelay
--
0
PMID: 15541655, 11544303, 11489980 expression of SLAM is markedly increased on DCs and B cells following activation through CD40, as well as in response to inflammatory stimuli such as lipopolysaccharide (LPS) or IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c50 : 1
stoichiometry:c53 : 1
m65*0.1
nodelay
--
0
PMID: 15541655, 11544303, 11489980 expression of SLAM is markedly increased on DCs and B cells following activation through CD40, as well as in response to inflammatory stimuli such as lipopolysaccharide (LPS) or IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c54 : 1
m68*0.1
nodelay
--
0
PMID: 15541655, 11544303, 11489980 expression of SLAM is markedly increased on DCs and B cells following activation through CD40, as well as in response to inflammatory stimuli such as lipopolysaccharide (LPS) or IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c55 : 1
m69*0.1
nodelay
--
0
PMID: 15541655, 11544303, 11489980 expression of SLAM is markedly increased on DCs and B cells following activation through CD40, as well as in response to inflammatory stimuli such as lipopolysaccharide (LPS) or IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c17 : 1
m2566*m6*0.1
nodelay
--
0
PMID: 15541655 SAP binds to tyrosines in the intra-cytoplasmic domain of SLAM family receptors. PMID: 15541655, 9774102, 11698418, 12928397 SAP interacts by way of its SH2 domain with tyrosine-based motifs in the cytoplasmic domain of SLAM family receptors, including SLAM, 2B4, CD84, NTB-A (Ly-108 in the mouse), Ly-9.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c56 : 1
m72*0.1
nodelay
--
0
PMID: 15541655, 12351401 expression of SLAM is enhanced after activation of macrophages with LPS and IFN-gamma.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m71*m1639*0.1
nodelay
--
0
PMID: 15541655, 12351401 expression of SLAM is enhanced after activation of macrophages with LPS and IFN-gamma.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m2565*m73*0.1
nodelay
--
0
PMID: 15541655, 10570270 Both in human and mouse T cells, SLAM ligation by soluble anti-SLAM antibodies was observed to increase the production of TH1-type cytokines, including IFN-gamma and TNF-alpha, without affecting the production of TH2 cytokines like IL-4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m74*0.1
nodelay
--
0
PMID: 15541655, 10570270 Both in human and mouse T cells, SLAM ligation by soluble anti-SLAM antibodies was observed to increase the production of TH1-type cytokines, including IFN-gamma and TNF-alpha, without affecting the production of TH2 cytokines like IL-4.
p24
p24
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c69 : 1
stoichiometry:c68 : 1
m46*m93439*0.1
nodelay
--
0
PMID: 15541655 This finding established that SLAM is an activator of IL-4 production. PMID: 15541655 the role of SLAM in IL-4 production is likely to be dependent on SAP.
p25
p25
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c74 : 1
stoichiometry:c85 : 1
stoichiometry:c71 : 1
m93589*m69*m2565*0.1
nodelay
--
0
PMID: 15541655 Lipopolysaccharide (LPS)-induced production of IL-12, TNF-alpha and nitric oxide (NO) was diminished in slam¡Ý/¡Ý macrophages, whereas the release of IL-6 was enhanced.
p26
p26
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c75 : 1
stoichiometry:c81 : 1
m69*m93309*0.1
nodelay
--
0
PMID: 15541655 Lipopolysaccharide (LPS)-induced production of IL-12, TNF-alpha and nitric oxide (NO) was diminished in slam¡Ý/¡Ý macrophages, whereas the release of IL-6 was enhanced.
p27
p27
cso30:i:ME_UnknownProduction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c83 : 1
stoichiometry:c76 : 1
m69*m2565*0.1
nodelay
--
0
PMID: 15541655 Lipopolysaccharide (LPS)-induced production of IL-12, TNF-alpha and nitric oxide (NO) was diminished in slam¡Ý/¡Ý macrophages, whereas the release of IL-6 was enhanced.
p28
p28
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c77 : 1
stoichiometry:c78 : 1
stoichiometry:c82 : 1
stoichiometry:c79 : 1
m93248*m69*0.1
nodelay
--
0
PMID: 15541655 Lipopolysaccharide (LPS)-induced production of IL-12, TNF-alpha and nitric oxide (NO) was diminished in slam¡Ý/¡Ý macrophages, whereas the release of IL-6 was enhanced.
p29
p29
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c84 : 1
stoichiometry:c80 : 1
stoichiometry:c90 : 1
m36*m75*m76*m77*m93589*0.1
nodelay
--
0
PMID: 15541655, 8376943, 8326140, 10359122 Engagement of 2B4 by anti-2B4 antibodies or CD48 triggers degranulation-mediated cytotoxicity, as well as secretion of IFN-gamma and IL-2, by NK cells. PMID: 15541655 In human NK cells, 2B4-mediated cytotoxicity was shown to be dependent on co-engagement of other activating receptors such as NCRs and CD16 (Fc¦ÃRIII)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c7 : 1
stoichiometry:c64 : 1
stoichiometry:c8 : 1
m32*m2565*0.1
nodelay
--
0
PMID: 15541655, 14988414, 10831600, 11564780 SLAM, CRACC, CD84 and NTB-A are capable of homotypic interactions, while 2B4 interacts with the CD2-related receptor CD48. PMID: 15541655 The finding that anti-SLAM antibodies could inhibit SLAM homophilic interactions in vitro favored the possibility that these antibodies were in fact antagonistic.
p30
p30
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c91 : 1
stoichiometry:c94 : 1
stoichiometry:c88 : 1
stoichiometry:c87 : 1
m93423*m75*m76*m77*0.1
nodelay
--
0
PMID: 15541655, 8376943, 8326140, 10359122 Engagement of 2B4 by anti-2B4 antibodies or CD48 triggers degranulation-mediated cytotoxicity, as well as secretion of IFN-gamma and IL-2, by NK cells. PMID: 15541655 In human NK cells, 2B4-mediated cytotoxicity was shown to be dependent on co-engagement of other activating receptors such as NCRs and CD16 (Fc¦ÃRIII)
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m36*m41*0.1
nodelay
--
0
PMID: 15541655 2B4-mediated protein tyrosine phosphorylation is strictly dependent on SAP, and on the aptitude of SAP to recruit FynT.
p32
p32
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c100 : 1
stoichiometry:c99 : 1
m90*m77*0.1
nodelay
--
0
PMID: 15541655, 11034353, 11169415, 11815622 2B4 engagement may also trigger tyrosine phosphorylation of phospholipase C (PLC)-gamma, linker for activation of T cells (LAT) and the p85 subunit of phosphatidylinositol (PI) 3¡ì kinase.
p33
p33
cso30:i:ME_CytosolicCalciumIonConcentrationElevation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
m78*0.1
nodelay
--
0
PMID: 15541655 Consistent with the involvement of PLC-gamma, ligation of 2B4 can lead to intracellular Ca2+ fluxes and PI turnover.
p34
p34
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
stoichiometry:c105 : 1
m37916*m2533*0.1
nodelay
--
0
PMID: 15541655, 11169415, 11714782, 12077228 ndeed, 2B4 was reported to be constitutively associated with LAT in lipid rafts, by way of a dicysteine motif (CxC) located in the transmembrane portion of 2B4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c106 : 1
stoichiometry:c107 : 1
stoichiometry:c143 : 1
m42171*m81*0.1
nodelay
--
0
PMID: 15541655, 14988414 Antibody-mediated engagement of NTB-A on T cells was shown to induce its tyrosine phosphorylation and association with SAP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c109 : 1
stoichiometry:c110 : 1
m2566*m82*0.1
nodelay
--
0
PMID: 15541655, 14988414 Antibody-mediated engagement of NTB-A on T cells was shown to induce its tyrosine phosphorylation and association with SAP.
p37
p37
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c113 : 1
stoichiometry:c112 : 1
m93423*m83*0.1
nodelay
--
0
PMID: 15541655 This engagement also resulted in an enhancement of TCR-mediated T-cell proliferation and production of IFN-gamma, without affecting IL-4 secretion.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m35*0.1
nodelay
--
0
PMID: 15541655, 12928397 Biochemical analyses performed using B- and T cells showed that, upon ligation, CD84 becomes phosphorylated on tyrosine and inducibly associates with SAP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
stoichiometry:c118 : 1
m44946*m86*0.1
nodelay
--
0
PMID: 15541655, 11564780 Ligation of CD84 by soluble anti-CD84 antibodies or a CD84-Fc fusion was reported to increase IFN-gamma production by activated T cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c9 : 1
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m34*m37916*0.1
nodelay
--
0
PMID: 15541655, 14988414, 10831600, 11564780 SLAM, CRACC, CD84 and NTB-A are capable of homotypic interactions, while 2B4 interacts with the CD2-related receptor CD48.
p40
p40
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c120 : 1
stoichiometry:c121 : 1
m93423*m87*0.1
nodelay
--
0
PMID: 15541655, 11564780 Ligation of CD84 by soluble anti-CD84 antibodies or a CD84-Fc fusion was reported to increase IFN-gamma production by activated T cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c124 : 1
stoichiometry:c123 : 1
m37*m2808*0.1
nodelay
--
0
PMID: 15541655, 12928397 Co-engagement of CD84 and CD3 was also recently observed to enhance T-cell proliferation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c127 : 1
stoichiometry:c126 : 1
m89*m92*0.1
nodelay
--
0
PMID: 15541655, 15096483 ligation of Ly-9 by anti-Ly-9 antibodies was observed to induce Ly-9 tyrosine phosphorylation.
p43
p43
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
stoichiometry:c130 : 1
m91*m2566*0.1
nodelay
--
0
PMID: 15541655 This phosphorylation appears to be largely dependent on SAP, as it was almost abolished in T cells from sap¡Ý/¡Ý mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m93*0.1
nodelay
--
0
PMID: 15541655 This phosphorylation appears to be largely dependent on SAP, as it was almost abolished in T cells from sap¡Ý/¡Ý mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c135 : 1
stoichiometry:c134 : 1
m95*m2566*0.1
nodelay
--
0
PMID: 15541655, 10970093 human, but not mouse CRACC, could interact with SAP in transient transfection experiments.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c136 : 1
stoichiometry:c137 : 1
m80*0.1
nodelay
--
0
PMID: 15541655, 11034353, 11169415, 11815622 2B4 engagement may also trigger tyrosine phosphorylation of phospholipase C (PLC)-gamma, linker for activation of T cells (LAT) and the p85 subunit of phosphatidylinositol (PI) 3¡ì kinase.
p47
p47
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c139 : 1
stoichiometry:c140 : 1
m37916*m99*0.1
nodelay
--
0
PMID: 15541655, 11034353, 11169415, 11815622 2B4 engagement may also trigger tyrosine phosphorylation of phospholipase C (PLC)-gamma, linker for activation of T cells (LAT) and the p85 subunit of phosphatidylinositol (PI) 3¡ì kinase.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c142 : 1
m98*0.1
nodelay
--
0
PMID: 15541655, 11034353, 11169415, 11815622 2B4 engagement may also trigger tyrosine phosphorylation of phospholipase C (PLC)-gamma, linker for activation of T cells (LAT) and the p85 subunit of phosphatidylinositol (PI) 3¡ì kinase.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c12 : 1
stoichiometry:c14 : 1
m44946*m84*0.1
nodelay
--
0
PMID: 15541655, 14988414, 10831600, 11564780 SLAM, CRACC, CD84 and NTB-A are capable of homotypic interactions, while 2B4 interacts with the CD2-related receptor CD48.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c16 : 1
stoichiometry:c18 : 1
m2566*m85*0.1
nodelay
--
0
PMID: 15541655 SAP binds to tyrosines in the intra-cytoplasmic domain of SLAM family receptors. PMID: 15541655, 9774102, 11698418, 12928397 SAP interacts by way of its SH2 domain with tyrosine-based motifs in the cytoplasmic domain of SLAM family receptors, including SLAM, 2B4, CD84, NTB-A (Ly-108 in the mouse), Ly-9. PMID: 15541655, 12928397 Biochemical analyses performed using B- and T cells showed that, upon ligation, CD84 becomes phosphorylated on tyrosine and inducibly associates with SAP.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m38*m42171*0.1
nodelay
--
0
PMID: 15541655, 14988414, 10831600, 11564780 SLAM, CRACC, CD84 and NTB-A are capable of homotypic interactions, while 2B4 interacts with the CD2-related receptor CD48.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m2566*m39*0.1
nodelay
--
0
PMID: 15541655 SAP binds to tyrosines in the intra-cytoplasmic domain of SLAM family receptors. PMID: 15541655, 9774102, 11698418, 12928397 SAP interacts by way of its SH2 domain with tyrosine-based motifs in the cytoplasmic domain of SLAM family receptors, including SLAM, 2B4, CD84, NTB-A (Ly-108 in the mouse), Ly-9.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m41*m5*0.1
nodelay
--
0
PMID: 15541655, 11477403, 12545173, 12545174 SAP is absolutely required for SLAM-triggered protein tyrosine phosphorylation in T cells, due to the ability of SAP to promote the recruitment and activation of Src-related protein tyrosine kinase (PTK) FynT.
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--